These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 26048399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Matusik PT, Matusik PS, Kornacewicz-Jach Z, Małecka B, Ząbek A, Undas A.
    Int J Cardiol; 2017 Sep 15; 243():244-250. PubMed ID: 28571619
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M, Fil K, Bazanek M, Undas A.
    Thromb Haemost; 2014 Apr 01; 111(4):685-93. PubMed ID: 24306139
    [Abstract] [Full Text] [Related]

  • 6. Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation.
    Ząbczyk M, Majewski J, Lelakowski J.
    Pol Arch Med Wewn; 2011 Nov 01; 121(11):400-7. PubMed ID: 22064373
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Altered fibrin clot properties are associated with the progression of chronic kidney disease in atrial fibrillation.
    Heleniak Z, Matusik PT, Undas A.
    Thromb Res; 2024 Apr 01; 236():14-21. PubMed ID: 38387299
    [Abstract] [Full Text] [Related]

  • 9. Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex).
    Głowicki B, Matusik PT, Plens K, Undas A.
    Can J Cardiol; 2019 May 01; 35(5):634-643. PubMed ID: 30955928
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism.
    Palka I, Nessler J, Nessler B, Piwowarska W, Tracz W, Undas A.
    Heart; 2010 Jul 01; 96(14):1114-8. PubMed ID: 20610458
    [Abstract] [Full Text] [Related]

  • 13. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
    Mastalerz L, Celińska-Lӧwenhoff M, Krawiec P, Batko B, Tłustochowicz W, Undas A.
    PLoS One; 2015 Jul 01; 10(11):e0142167. PubMed ID: 26540111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation.
    Mołek P, Chmiel J, Ząbczyk M, Malinowski KP, Natorska J, Undas A.
    Int J Cardiol; 2022 Oct 15; 365():1-7. PubMed ID: 35868355
    [Abstract] [Full Text] [Related]

  • 17. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M, Blombäck M, Majewski J, Karkowski G, Wallen HN, Undas A, He S.
    Thromb Haemost; 2015 Apr 15; 113(4):851-61. PubMed ID: 25518887
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome.
    Asztabski M, Wypasek E, Ząbczyk M, Undas A.
    Thromb Res; 2014 Nov 15; 134(5):945-51. PubMed ID: 25194881
    [Abstract] [Full Text] [Related]

  • 20. Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications.
    Undas A, Zubkiewicz-Usnarska L, Helbig G, Woszczyk D, Kozińska J, Dmoszyńska A, Dębski J, Podolak-Dawidziak M, Kuliczkowski K.
    Blood Coagul Fibrinolysis; 2015 Sep 15; 26(6):621-7. PubMed ID: 26083985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.